Presenter Biography

Richard G. Weleber, M.D.

Director, Oregon Retinal Degeneration Center
Casey Eye Institute, Oregon Health and Science University

Richard G. Weleber, M.D., is director of the Oregon Retinal Degeneration Center at Casey Eye Institute, Oregon Health & Science University. He earned his medical degree from the University of Oregon Medical School, then completed an ophthalmology residency and two fellowships in medical genetics. Dr. Weleber also serves as director of Electrophysiology and Visual Function Service for the Casey Eye Institute. He is a principal investigator for the RPE65 gene replacement clinical trial for Leber congenital amaurosis sponsored by Applied Genetic Technologies Corporation. He is also a principal investigator for the StarGen ABCA4 gene replacement clinical trial for Stargardt disease and the UshStat MYO7A gene replacement clinical trial for Usher Syndrome Type 1B - both sponsored by Oxford Biomedica. In addition, Dr. Weleber serves as a principal investigator for the FFB-sponsored valproic acid clinical trial for retinitis pigmentosa. His ongoing research interests include clinical and molecular research for RP and related disorders, including syndromic forms of RP, and the development and validation of endpoints for clinical trials for retinal degenerations.

Meet our other presenters:

Keynote Speaker

• Michael Hingson, The Michael Hingson Group, Inc.

Presenters

• Isabelle Audo, M.D., PH.D., Quinze-Vingts Hospital
• Benjamin Bakall, Ph.D., University of Iowa
• William Beltran, D.V.M., Ph.D., School of Veterinary Medicine
• Eliot Berson, Massachusetts Eye and Ear Infirmary
• Kathy Blake
• Shannon Boye, University of Florida
• Rusty Bromley, Translational Research Acceleration via Consulting
• Tiffany Chan, O.D., Wilmer Eye Institute, Johns Hopkins University
• Charlie Collins, Vision Dynamics, LLC
• Stephen Daiger, University of Texas Health Science Center in Houston
• Arlene Drack
• Jacque L. Duncan, M.D., University of California, San Francisco
• Timothy Elder, TRE Legal Practice, LLC
• Gerald Fishman, M.D., The Chicago Lighthouse for People Who are Blind or Visually Impaired
• David M. Gamm, M.D., Ph.D., University of Wisconsin-Madison
• Duane R. Geruschat, Ph.D., Salus University
• Douglas Goist, National Industries for the Blind
• Michael Grassi
• James T. Handa, M.D., Wilmer Eye Institute, Johns Hopkins University
• Rod Haneline, Leader Dogs for the Blind
• Brian Hurley, National Industries for the Blind
• Christine Kay, M.D., University of Florida
• Mark E. Kleinman, M.D.
• Craig MacFarlane, Edward Jones Company
• Toni March, Office of Blindness and Vision Services, Division of Rehabilitation Services
• Michel Michaelides
• Muna Naash
• Mark Pennesi, M.D., Ph.D., Casey Eye Institute
• Darlene Peregoy, Office for Blindness and Vision Services, Division of Rehabilitation Services
• Eric Pierce, Massachusetts Eye and Ear Infirmary
• Dan Roberts, Macular Degeneration Support
• José-Alain Sahel, M.D.
• Philip Saunders
• Hendrik Scholl
• Everett T. Shupe II, MBA, CAE, CMP, Shupe Plans
• Janet Sunness, M.D., Hoover Low Vision Rehabilitation Services, Greater Baltimore Medical Center
• Karmen M Trzupek, MS, CGC, Informed Medical Decisions, Inc.
• Dawn E. Turco, Hadley School for the Blind
• Lou Tutt, Association for Education and Rehabilitation of the Blind and Visually Impaired
• Luk H. Vandenberghe, Ph.D., HMassachusetts Eye and Ear Infirmary and Harvard Medical School
• Douglas Walker, Hadley School for the Blind
• Richard G. Weleber, M.D., Casey Eye Institute, Oregon Health and Science University
• Dan Wenzel, Blind Industries and Services of Maryland
• Kim Walker, Tennessee School for the Blind
• Sandy White, Blind Sports Organization
• Paul Yang, M.D., Ph.D., University of Utah
• Donald Zack
• Michael Zuber